as declared in sabc
The how, what and why of the latest HIV vaccine trial :Tuesday 1 November 2016
The how, what and why of the latest HIV vaccine trial :Tuesday 1 November 2016
South Africa has 7 million people with HIV, almost one-fifth of the global HIV positive population(SABC)Explainer: the how, what and why of the latest HIV vaccine trialAs the global quest for an HIV vaccine continues, Linda-Gail Bekker explains the significance of the latest large-scale trial underway in South Africa.What's the significance of the trial for the global fight against HIV?The world needs an HIV vaccine.
coupled with miamiherald
In a first, US trial to test Cuban lung-cancer vaccine
In a first, US trial to test Cuban lung-cancer vaccine
2:02 Changes are coming in Cuba, more for some than others Pause1:04 Cuban Cigars: A smoking view of the tobacco fields7:19 Voting rights are revoked2:32 Big Additions: Marchessault, Sceviour lead Florida Panthers in scoring1:45 Heroin antidote becomes available without prescription1:19 Bus monitor punches preschooler1:27 'World's worst mom' says parents should let kids play1:35 Fresno police turn to yoga to relieve stress, improve health3:33 Day of the Dead skydive with Roberta Mancino
as well enca
HIV vaccine trial gets under way
HIV vaccine trial gets under way
JOHANNESBURG, 01 November 2016 – More than 5,000 South Africans are participating in an historic HIV vaccine trial that started on Thursday.eNCA's Uveka Rangappa speaks to Desmond Tutu HIV Foundation deputy director, Linda Gail Bekker.Video: eNCAJohannesburg, 1 November 2016 - SA resumes the four-year clinical trial to possible HIV prevention vaccine this week.
No comments:
Post a Comment